Followers | 11 |
Posts | 190 |
Boards Moderated | 0 |
Alias Born | 06/28/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 20, 2018 2:42:17 PM
BY MT Newswires
— 9:08 AM ET 09/20/2018
09:08 AM EDT, 09/20/2018 (MT Newswires) -- OncoMed Pharmaceuticals ( OMED)said Thursday that Celgene ( CELG ) has decided not to exercise its option to license the bispecific antibody navicixizumab and said both companies were working to formalize the termination of the collaboration agreement.
OncoMed said it expects to retain worldwide rights to navicixizumab and is currently conducting a phase 1b clinical trial in combination with paclitaxel in patients with platinum-resistant late-stage ovarian cancer.
Celgene ( CELG ) continues to retain its options to license OncoMed's etigilimab and rosmantuzumab under the collaboration.
Price: 2.80, Change: -0.11, Percent Change: -3.78
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Intersting timing IMO
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM